Wellington Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
588
-116
-16% -$43K 0.06% 140
2026
Q1
$206K Buy
704
+436
+163% +$143K 0.06% 145
2025
Q4
$93.9K Buy
+268
New +$90.6K 0.03% 187

Other funds holding ELV

Wellington Group's ELV Position: Q2 2026 in Review

Wellington Group reduced its Elevance Health (ELV) stake by 16% in Q2 2026, selling an estimated $43K and leaving 588 shares worth $227K. The position accounts for 0.06% of the portfolio, ranked #140.

Wellington Group first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wellington Group held 588 shares of Elevance Health worth $227K as of Q2 2026.
  • Wellington Group sold 116 Elevance Health shares in Q2 2026, an estimated $43K.
  • Elevance Health made up 0.06% of Wellington Group's portfolio in Q2 2026, its #140 holding.
  • Wellington Group first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wellington Group's 13F filing for Q2 2026, filed 14 Aug 2026.